MaRS Mornings: Steve Plymale on turning ‘no’ into ‘yes’
What venture capitalists are looking for: An insider’s perspective
Biotech-Pharma deals get no respect
RBC is investing for impact with the MaRS Cleantech Fund
Making it easy to do the right thing